Latest period
$43.80M
YoY change
+194.2%
5Y CAGR
+8.6%
Peak year (2021)
$1.73B
Latest annual
$1.60B
Operating Cash Flow history chart for Edwards Lifesciences (EW) from 1999 to 2025
Latest: $1.60B
Operating Cash Flow growth chart for Edwards Lifesciences (EW) from 1999 to 2025
Latest: +194.2%
Operating Cash Flow history table for Edwards Lifesciences (EW) from 1999 to 2025
| 2025 | $1.60B | +194.2% | +$1.05B | ||
| 2024 | $542.30M | -39.5% | −$353.50M | ||
| 2023 | $895.80M | -26.5% | −$322.40M | ||
| 2022 | $1.22B | -29.7% | −$513.90M | ||
| 2021 | $1.73B | +64.3% | +$677.80M | ||
| 2020 | $1.05B | -10.6% | −$125.10M | ||
| 2019 | $1.18B | +27.3% | +$252.60M | ||
| 2018 | $926.80M | -7.4% | −$73.90M | ||
| 2017 | $1.00B | +42.1% | +$296.30M | ||
| 2016 | $704.40M | +28.1% | +$154.70M | ||
| 2015 | $549.70M | -46.2% | −$472.60M | ||
| 2014 | $1.02B | +116.3% | +$549.60M | ||
| 2013 | $472.70M | +26.5% | +$98.90M | ||
| 2012 | $373.80M | +18.9% | +$59.30M | ||
| 2011 | $314.50M | +25.1% | +$63.10M | ||
| 2010 | $251.40M | +52.1% | +$86.10M | ||
| 2009 | $165.30M | +7.9% | +$12.10M | ||
| 2008 | $153.20M | -27.1% | −$57.00M | ||
| 2007 | $210.20M | -8.9% | −$20.60M | ||
| 2006 | $230.80M | +68.7% | +$94.00M | ||
| 2005 | $136.80M | -24.3% | −$43.80M | ||
| 2004 | $180.60M | +47.7% | +$58.30M | ||
| 2003 | $122.30M | +1.4% | +$1.70M | ||
| 2002 | $120.60M | +19.4% | +$19.60M | ||
| 2001 | $101.00M | -26.3% | −$36.00M | ||
| 2000 | $137.00M | -22.2% | −$39.00M | ||
| 1999 | $176.00M | — | — |
- 2025$1.60B+194.2%
- 2024$542.30M-39.5%
- 2023$895.80M-26.5%
- 2022$1.22B-29.7%
- 2021$1.73B+64.3%
- 2020$1.05B-10.6%
- 2019$1.18B+27.3%
- 2018$926.80M-7.4%
- 2017$1.00B+42.1%
- 2016$704.40M+28.1%
- 2015$549.70M-46.2%
- 2014$1.02B+116.3%
- 2013$472.70M+26.5%
- 2012$373.80M+18.9%
- 2011$314.50M+25.1%
- 2010$251.40M+52.1%
- 2009$165.30M+7.9%
- 2008$153.20M-27.1%
- 2007$210.20M-8.9%
- 2006$230.80M+68.7%
- 2005$136.80M-24.3%
- 2004$180.60M+47.7%
- 2003$122.30M+1.4%
- 2002$120.60M+19.4%
- 2001$101.00M-26.3%
- 2000$137.00M-22.2%
- 1999$176.00M—
Operating Cash Flow values are taken from Edwards Lifesciences's reported cash flow statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Operating Cash Flow at Edwards Lifesciences (EW)
Operating Cash Flow for Edwards Lifesciences (EW): headline value $43.80M · YoY +194.2%. Annual and quarterly series, chart, and tables are below.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
As of the 2025 fiscal year, Edwards Lifesciences (EW) reported operating cash flow of $1.60B – surged 194.2% year-over-year.
Through 2020–2025 (5 years), Edwards Lifesciences operating cash flow delivered a +8.6% annualised rate; with mixed annual results across the window.
Edwards Lifesciences operating cash flow declined from $1.73B in 2021 to $1.60B in 2025, a 7.9% drawdown.
The record annual operating cash flow stands at $1.73B, reached in 2021; the historical low of $101.00M was recorded in 2001.
Edwards Lifesciences Operating Cash Flow by Year
Edwards Lifesciences Operating Cash Flow 2025: $1.60B
Edwards Lifesciences posted operating cash flow of $1.60B in 2025, surged 194.2% from 2024.
Edwards Lifesciences Operating Cash Flow 2024: $542.30M
In 2024, Edwards Lifesciences reported operating cash flow of $542.30M, plunged 39.5% below 2023.
Edwards Lifesciences Operating Cash Flow 2023: $895.80M
Edwards Lifesciences operating cash flow in 2023 was $895.80M, declined 26.5% below 2022.
Edwards Lifesciences Operating Cash Flow 2022: $1.22B
2022's operating cash flow for Edwards Lifesciences came in at $1.22B, declined 29.7% below 2021.
Edwards Lifesciences Operating Cash Flow 2021: $1.73B
Edwards Lifesciences operating cash flow in 2021 was $1.73B.
See more financial history for Edwards Lifesciences (EW).
Sector peers by Operating Cash Flow
Healthcare peers of Edwards Lifesciences (EW), ranked by their latest operating cash flow
| $24.53B | |
| $19.70B | |
| $19.03B | |
| $18.56B | |
| $16.81B | |
| $16.47B | |
| $14.57B | |
| $9.96B |
- $24.53B
- $19.70B
- $19.03B
- $18.56B
- $16.81B
- $16.47B
- $14.57B
- $9.96B
Frequently asked questions
Edwards Lifesciences (EW) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation